Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$438,894,471
-$15,699,645 QoQ
Shares Held
13,172,103
+0.2% QoQ
Ownership
15.0%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 99.99015343259919.ToString("F0")%
Shared 0.ToString("F0")%
None 0.00984656740081671.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. IDYA ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in IDYA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $438,894,471 | 13,172,103 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $454,594,116 | 13,149,960 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $357,717,487 | 13,146,545 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $276,145,918 | 13,137,294 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $215,077,490 | 13,130,494 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $333,152,979 | 12,963,151 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $400,297,486 | 12,635,653 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $395,692,612 | 11,270,083 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $445,612,544 | 10,155,254 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $31,602,475 | 888,209 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $29,603,561 | 1,097,241 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $25,777,103 | 1,096,898 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,984,255 | 581,519 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $10,123,415 | 557,150 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,543,081 | 773,665 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $8,628,159 | 625,229 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,105,784 | 992,474 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,195,107 | 1,319,590 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,201,990 | 361,004 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $938,588 | 44,716 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,984 | 127 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||